Investors
Genomic Vision is a publicly-traded company on the Euronext regulated market in Paris
Regulated Information
Financial Reports
2022
April 28, 2022 : Rapport financier annuel 2021 (chapitre 5) French version
April 28, 2022 : Rapport financier annuel 2021 (sauf chapitre 5) French version
April 15, 2022: Information mise à disposition du document d’enregistrement universel French version
April 15, 2022: Document universel d’enregistrement (sauf Chapitre 5) French version.
April 15, 2022: Document universel d’enregistrement (Chapitre 5) French version
Click here to access the French Documentation: “Suivi du programme d’Ocabsa avec Winance”
2021
Click here to access the French documentation “Suivi du programme d’OCABSA avec Winance“
Click here to access the French documentation “Rapport financier semestriel au 30 juin 2021”
Click here to access the French documentation “Suivi du programme d’OCABSA avec Winance“
Click here to access the French documentation “Rapport Financier Semestriel du 30 Juin 2020“
Click here to access the French documentation “Rapport Financier Annuel 2019“
First Semester Financial Report 2019 (French)
Reference document 2018 (French) part 1 excl section 20.4 Financial statements French GAAP p234-266
Reference document 2018 (French) part 2 section 20.4 Financial statements French GAAP p234-266
First Semester Financial Report 2018 (French)
Annual Financial Report 2017 (French)
First Semester Financial Report 2017 (French)
Reference document 2016 (French)
First Semester Financial Report 2016 (French)
Annual Financial Report 2015 (French)
First Semester Financial Report 2015 (French)
Annual Financial Report 2014 (French)
First Semester Financial Report 2014 (French)
Monthly Statement
> Information on December 31, 2019 (French)
Articles of association (French)
ABSA Prospectus (French)
> ABSA Prospectus – note d’opération (French)
IPO Prospectus (French)
Half-yearly report on the liquidity contract (French)
Rules of procedure of the supervisory board (French)
Press Releases
